Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Top Cited Papers
Open Access
- 15 June 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 16 (7), 381-400
- https://doi.org/10.1038/s41582-020-0362-2
Abstract
Pain medication plays an important role in the treatment of acute and chronic pain conditions, but some drugs, opioids in particular, have been overprescribed or prescribed without adequate safeguards, leading to an alarming rise in medication-related overdose deaths. The NIH Helping to End Addiction Long-term (HEAL) Initiative is a trans-agency effort to provide scientific solutions to stem the opioid crisis. One component of the initiative is to support biomarker discovery and rigorous validation in collaboration with industry leaders to accelerate high-quality clinical research into neurotherapeutics and pain. The use of objective biomarkers and clinical trial end points throughout the drug discovery and development process is crucial to help define pathophysiological subsets of pain, evaluate target engagement of new drugs and predict the analgesic efficacy of new drugs. In 2018, the NIH-led Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain workshop convened scientific leaders from academia, industry, government and patient advocacy groups to discuss progress, challenges, gaps and ideas to facilitate the development of biomarkers and end points for pain. The outcomes of this workshop are outlined in this Consensus Statement.Keywords
This publication has 223 references indexed in Scilit:
- Wisdom of crowds for robust gene network inferenceNature Methods, 2012
- Corticostriatal functional connectivity predicts transition to chronic back painNature Neuroscience, 2012
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural MechanismsNeuron, 2012
- Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E2 in the spinal cordPain, 2012
- Towards a Physiology-Based Measure of Pain: Patterns of Human Brain Activity Distinguish Painful from Non-Painful Thermal StimulationPLOS ONE, 2011
- The painful face – Pain expression recognition using active appearance modelsImage and Vision Computing, 2009
- Neuropathic Pain: A Maladaptive Response of the Nervous System to DamageAnnual Review of Neuroscience, 2009
- The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathologyBrain, 2008
- Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disordersJCI Insight, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001